Rockville, Maryland, United States Funds with similar focus
| Fund Name | Location |
| Apollo Investment Corporation | New York, New York, United States |
| Archipelago | California, Mill Valley, United States |
| Blue Haven Initiative | Cambridge, Massachusetts, United States |
| CreatiFi | - |
| ECCO | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
| LOI Labs | British Columbia, Canada, Vancouver |
| Mantra Investment Partners | - |
| Meihe Touzi | Beijing, China, Shijingshan |
| Microsoft for Startups | Redmond, United States, Washington |
| Mid-Atlantic Angel Group | Pennsylvania, Philadelphia, United States |
| Newcastle Science City | Newcastle upon Tyne, North East, United Kingdom |
| PacRim Venture Partners | California, Menlo Park, United States |
| Parkway Venture Capital | New York, New York, United States |
| Point9 | - |
| Positive Ventures | Brazil, São Paulo, São Paulo |
| Shenzhen V&T Technologies | China, Guangdong, Shenzhen |
| Sinuo Chengzhang Investment Management | Beijing, Beijing, China |
| Tessera Capital Partners | - |
| Zhuoyuan Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Corridor Pharmaceuticals | $13M | 24 Jun 2010 | Towson, Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Corridor Pharmaceuticals | $13M | 24 Jun 2010 | Towson, Maryland, United States |
